Monoclonal Antibody News and Research

RSS
Monoclonal antibodies (MAbs) are produced from a single B cell clone and can bind to a single type of antigen binding site. MAbs are homogenous antibodies that cannot form lattices with monomeric proteins as they can bind to only a single epitope on the antigen. Developed in the 1970s, MAbs can be produced against any given substance. Thus they can be used to detect and purify any substance of interest. This has made MAbs a powerful tool of molecular biology, biochemistry, and medicine.
New study finds maternal vaccine and monoclonal antibody effective against RSV in infants

New study finds maternal vaccine and monoclonal antibody effective against RSV in infants

New Omicron subvariants test vaccine limits, reveal unique infection challenges

New Omicron subvariants test vaccine limits, reveal unique infection challenges

SARS-CoV-2 BA.2.86 shows increased lung targeting despite vaccine effectiveness

SARS-CoV-2 BA.2.86 shows increased lung targeting despite vaccine effectiveness

Bridging ideas to IND: Nona Biosciences' year of impact in biotechnology

Bridging ideas to IND: Nona Biosciences' year of impact in biotechnology

New vaccine strategy targets SARS-CoV-2's stable S2 subunit, offering broad protection against evolving variants

New vaccine strategy targets SARS-CoV-2's stable S2 subunit, offering broad protection against evolving variants

Antibody treatment shields transplant patients against COVID-19

Antibody treatment shields transplant patients against COVID-19

Small molecule applications of process Raman spectroscopy

Small molecule applications of process Raman spectroscopy

Promising candidate medication for preventing and reversing fentanyl-induced overdose

Promising candidate medication for preventing and reversing fentanyl-induced overdose

New mechanism revealed for how group A Streptococcus infection reduces type 1 diabetes risk

New mechanism revealed for how group A Streptococcus infection reduces type 1 diabetes risk

Survey: Over a third of Americans worry about the "tripledemic" of respiratory illnesses

Survey: Over a third of Americans worry about the "tripledemic" of respiratory illnesses

B-BiTE modality enhances anti-myeloma effects of clinically available antibodies

B-BiTE modality enhances anti-myeloma effects of clinically available antibodies

Gene splicing determines CD20 levels and response to monoclonal antibody therapy

Gene splicing determines CD20 levels and response to monoclonal antibody therapy

One in five patients on Nirmatrelvir–Ritonavir experience virologic rebound, new observational study reveals

One in five patients on Nirmatrelvir–Ritonavir experience virologic rebound, new observational study reveals

Fecal microbiota transplantation boosts survival in metastatic colorectal cancer treatment

Fecal microbiota transplantation boosts survival in metastatic colorectal cancer treatment

Abelacimab significantly reduces bleeding risk in atrial fibrillation patients with stroke risk

Abelacimab significantly reduces bleeding risk in atrial fibrillation patients with stroke risk

Tumor-immune interactions predict treatment responses in multiple myeloma

Tumor-immune interactions predict treatment responses in multiple myeloma

New hope for preventing preterm births: IL-6R blockade reduces neonatal mortality

New hope for preventing preterm births: IL-6R blockade reduces neonatal mortality

A new RSV shot could help protect babies this winter — if they can get it in time

A new RSV shot could help protect babies this winter — if they can get it in time

Patients with advanced HER2-positive breast cancer live longer if treated with pyrotinib, trial shows

Patients with advanced HER2-positive breast cancer live longer if treated with pyrotinib, trial shows

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.